Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer
Clinical trial NCT00529100 · COMPLETED
Trial details
- NCT number
- NCT00529100
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2010-08-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.